SIMCor
In Silico testing and validation of Cardiovascular Implantable devices
Duration
2021-2024
Coordinated by
Charite Universitaetsmedizin Berlin
Projects Partners
12
Project funding
7.2M €
The Project
SIMCor was an EU-funded initiative tackling one of the biggest challenges in medical device innovation: the costly and time-consuming verification and validation phase. As regulatory demands for safety and performance grow, SIMCor developed a computational platform that supports the in silico development, testing, and regulatory approval of cardiovascular implants. By combining virtual cohort generation, device implantation simulations, and modelling tools for collaborative R&D, the project aimed at lowering barriers to adoption and enabling faster, safer innovation in cardiovascular care.
Our role in the project
As a key partner, VPH led the project’s efforts on standards development, dissemination, and stakeholder engagement. We coordinated the creation of standard operating procedures (SOPs) and guidelines for in silico testing, and worked closely with clinical, academic, and industrial partners to ensure broad alignment and impact. Through our communication and outreach activities, we leveraged the VPH network to amplify SIMCor’s methodologies and foster their adoption across Europe’s digital health ecosystem.